Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compromised fatty acid oxidation in mitochondrial disorders

L Hagenfeldt1

  • 1Department of Laboratory Sciences and Technology, Karolinska Institutet, Huddinge University Hospital, Sweden.

Journal of Inherited Metabolic Disease
|September 5, 1998
PubMed
Summary

Measuring palmitate oxidation helps detect mitochondrial beta-oxidation disorders and respiratory chain dysfunction. Clinical and metabolite data aid in differentiating these conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two novel aspartoacylase gene (ASPA) missense mutations specific to Norwegian and Swedish patients with Canavan disease.

Journal of medical genetics·2002
Same author

Aberrant tyrosine transport across the cell membrane in patients with schizophrenia.

Archives of general psychiatry·2001
Same author

Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.

Pediatrics·2001
Same author

Patent ductus venosus does not lead to alimentary galactosaemia in preterm infants.

Acta paediatrica (Oslo, Norway : 1992)·2001
Same author

D-2-hydroxyglutaric aciduria with cerebral, vascular, and muscular abnormalities in a 14-year-old boy.

Journal of child neurology·2000
Same author

Tyrosine transport is regulated differently in patients with schizophrenia.

Schizophrenia research·1999

Area of Science:

  • Biochemistry
  • Cell Biology
  • Medical Genetics

Background:

  • Mitochondrial beta-oxidation disorders and respiratory chain dysfunction are significant causes of inherited metabolic diseases.
  • Accurate diagnosis is crucial for effective patient management and genetic counseling.

Purpose of the Study:

  • To evaluate the utility of the tritium release method for detecting mitochondrial beta-oxidation disorders.
  • To assess the method's ability to identify patients with respiratory chain dysfunction.
  • To explore the role of clinical presentation and metabolite analysis in differential diagnosis.

Main Methods:

  • Measurement of palmitate oxidation using the tritium release assay in cultured fibroblasts and lymphocytes.
  • Clinical evaluation of patient symptoms and medical history.
  • Analysis of serum and urine metabolite levels.

Main Results:

  • The tritium release method successfully detected patients with mitochondrial beta-oxidation disorders.
  • The assay also identified a significant number of patients with respiratory chain dysfunction.
  • Clinical data and metabolite profiles provided valuable information for distinguishing between these two groups of disorders.

Conclusions:

  • Palmitate oxidation measurement via tritium release is a valuable tool for diagnosing mitochondrial beta-oxidation disorders and respiratory chain dysfunction.
  • Integrating biochemical assays with clinical and metabolite data enhances diagnostic accuracy for these complex mitochondrial diseases.

Related Experiment Videos